Ken Takanashi

Ken Takanashi is a declared insider at 2 companies; the most frequent names are Wave Life Sciences Ltd. and Satsuma Pharmaceuticals, Inc. The record holds 7 filings, for trades running from 6 June 2023 to 5 October 2026.

Both buying and selling appear: 1 purchase worth €18.8M, against 2 sales worth €57k. The net balance comes to €18.7M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. Since January 2026: no purchases and 1 sale on the market.

On 7 October 2026 came the latest disclosure, a share grant in Wave Life Sciences Ltd. The last purchase on record was published on 8 June 2023, which is 1,228 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.